2024, balance. Our capital allocation priorities also include returning cash to shareholders through a commitment to the dividend. 2025 marks our 93rd consecutive year of dividend payments. On Slide 19, I'll provide more detail on
Ex-Dividend Date Jan 3, 2025 Beta 0.45 Short Interest 27.52M (01/15/25) Short Interest Change 10.36% Percent of Float 1.36% Advanced $ 1D Compare Chart Line chart with 630 data points. The chart has 1 X axis displaying Time. Range: 2025-02-03 09:23:42 to 2025-02-03 20:05:17....
Dividend $0.62 Ex-Dividend Date Jan 3, 2025 Short Interest 27.52M 01/15/25 % of Float Shorted 1.36% Average Volume 11.31M Performance 5 Day -6.07% 1 Month -0.38% 3 Month -5.91% YTD -1.82% 1 Year 14.00% Analyst Ratings Sell Under Hold Over Buy Number of Ratings 29 Full ...
The annualized dividend paid by Bristol Myers Squibb Co. is $2.4/share, currently paid in quarterly installments, and its most recent dividend ex-date was on 10/04/2024. Below is a long-term dividend history chart for BMY, which the report stressed as being of key importance....
Ex-Dividend DateOct 31, 2024 Short InterestN/A % of Float ShortedN/A Average Volume323.72K Performance 5 Day -7.62% 1 Month -10.88% 3 Month -8.73% YTD -10.09% 1 Year 31.74% Recent News Bloomsbury Publishing Reports Record Revenue, Profit ...
Last Dividend Ex-DateJan 03, 2025 Dividend Yield4.02% Share Statistics EPS (TTM)-3.60 Shares Outstanding2,028,176,600 10 Day Avg. Volume9,576,052 30 Day Avg. Volume10,975,610 Standard Deviation0.06 R-Squared0.14 Alpha-0.00233 Financial Highlights & Ratios PEG RatioN/A Price to Book (P/...
Dividend ETFs Emerging Market ETFs Global and Regional ETFs Growth vs. Value ETFs Market Cap ETFs Real Estate ETFs Sector ETFs ETF Strategies Smart Beta Themes & Subsectors ETFs Cryptocurrency Market News Top News Trending News On the Move Market Pulse Global Markets Notable Calls Buybacks Commodit...
Dividend Yield 4.32% Beta 0.45 Frequently Asked Questions What sell-side analysts currently cover shares of Bristol-Myers Squibb? The following Wall Street analysts have issued stock ratings on Bristol-Myers Squibb in the last twelve months: Bank of America Co., Barclays PLC, BMO Capital Market...
ratio is 1.38. the current dividend yield of bmy is close to 3.23%, and the company continues to return value to shareholders through share repurchases. we should also remember that even if the covid-19 pandemic wreaks havoc with the economy and continues unabated for many more months, ...
IPO Date 2011-08-30 Description Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to ...